Morgan Stanley has initiated coverage on Ashland Inc (ASH) with an Equal-Weight rating, marking the firm's first assessment of the company. This decision reflects an analysis of Ashland's business, industry dynamics, and growth prospects.
Headquartered in Wilmington, Delaware, Ashland Inc is a prominent player in the chemicals sector, providing additives and specialty ingredients across various markets. The company serves customers in architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals, employing approximately 2,960 full-time staff.
As of September 7, 2025, Ashland's shares are trading at $49.28. The company's market capitalization stands at $2.2 billion, with a trailing twelve months (TTM) earnings per share (EPS) of -18.29 and a dividend yield of 338.7%.
Upcoming earnings reports are scheduled for July 27, 2026, with an EPS estimate of $1.26 and revenue estimate of $484.5 million, and April 28, 2026, with an EPS estimate of $1.12 and revenue estimate of $494.1 million. Recent performance has shown variability, with Q4 2025 reporting an EPS of $1.08, falling short of the $1.26 estimate by 14%.
Analyst consensus as of November 1, 2025, indicates 4 Strong Buy, 7 Buy, and 6 Hold ratings, with no Sell or Strong Sell recommendations, suggesting a general positive outlook among analysts.
Analyst ratings serve as professional opinions derived from research and financial models. While they can provide valuable insights, investors should consider a range of factors, including company fundamentals and industry trends, in their decision-making processes. Ratings may evolve over time as new information becomes available, highlighting the importance of staying informed.